Topographic distribution of inflammation factors in a healing aneurysm.
Animal
Endovascular procedures
Inflammation
Intracranial aneurysm
Models
Neointima
Journal
Journal of neuroinflammation
ISSN: 1742-2094
Titre abrégé: J Neuroinflammation
Pays: England
ID NLM: 101222974
Informations de publication
Date de publication:
02 Aug 2023
02 Aug 2023
Historique:
received:
23
05
2023
accepted:
26
07
2023
medline:
4
8
2023
pubmed:
3
8
2023
entrez:
2
8
2023
Statut:
epublish
Résumé
Healing of intracranial aneurysms following endovascular treatment relies on the organization of early thrombus into mature scar tissue and neointima formation. Activation and deactivation of the inflammation cascade plays an important role in this process. In addition to timely evolution, its topographic distribution is hypothesized to be crucial for successful aneurysm healing. Decellularized saccular sidewall aneurysms were created in Lewis rats and coiled. At follow-up (after 3 days (n = 16); 7 days (n = 19); 21 days (n = 8)), aneurysms were harvested and assessed for healing status. In situ hybridization was performed for soluble inflammatory markers (IL6, MMP2, MMP9, TNF-α, FGF23, VEGF), and immunohistochemical analysis to visualize inflammatory cells (CD45, CD3, CD20, CD31, CD163, HLA-DR). These markers were specifically documented for five regions of interest: aneurysm neck, dome, neointima, thrombus, and adjacent vessel wall. Coiled aneurysms showed enhanced patterns of thrombus organization and neointima formation, whereas those without treatment demonstrated heterogeneous patterns of thrombosis, thrombus recanalization, and aneurysm growth (p = 0.02). In coiled aneurysms, inflammation markers tended to accumulate inside the thrombus and in the neointima (p < 0.001). Endothelial cells accumulated directly in the neointima (p < 0.0001), and their presence was associated with complete aneurysm healing. The presence of proinflammatory cells plays a crucial role in aneurysm remodeling after coiling. Whereas thrombus organization is hallmarked by a pronounced intra-thrombotic inflammatory reaction, neointima maturation is characterized by direct invasion of endothelial cells. Knowledge concerning topographic distribution of regenerative inflammatory processes may pave the way for future treatment modalities which enhance aneurysm healing after endovascular therapy.
Sections du résumé
BACKGROUND
BACKGROUND
Healing of intracranial aneurysms following endovascular treatment relies on the organization of early thrombus into mature scar tissue and neointima formation. Activation and deactivation of the inflammation cascade plays an important role in this process. In addition to timely evolution, its topographic distribution is hypothesized to be crucial for successful aneurysm healing.
METHODS
METHODS
Decellularized saccular sidewall aneurysms were created in Lewis rats and coiled. At follow-up (after 3 days (n = 16); 7 days (n = 19); 21 days (n = 8)), aneurysms were harvested and assessed for healing status. In situ hybridization was performed for soluble inflammatory markers (IL6, MMP2, MMP9, TNF-α, FGF23, VEGF), and immunohistochemical analysis to visualize inflammatory cells (CD45, CD3, CD20, CD31, CD163, HLA-DR). These markers were specifically documented for five regions of interest: aneurysm neck, dome, neointima, thrombus, and adjacent vessel wall.
RESULTS
RESULTS
Coiled aneurysms showed enhanced patterns of thrombus organization and neointima formation, whereas those without treatment demonstrated heterogeneous patterns of thrombosis, thrombus recanalization, and aneurysm growth (p = 0.02). In coiled aneurysms, inflammation markers tended to accumulate inside the thrombus and in the neointima (p < 0.001). Endothelial cells accumulated directly in the neointima (p < 0.0001), and their presence was associated with complete aneurysm healing.
CONCLUSION
CONCLUSIONS
The presence of proinflammatory cells plays a crucial role in aneurysm remodeling after coiling. Whereas thrombus organization is hallmarked by a pronounced intra-thrombotic inflammatory reaction, neointima maturation is characterized by direct invasion of endothelial cells. Knowledge concerning topographic distribution of regenerative inflammatory processes may pave the way for future treatment modalities which enhance aneurysm healing after endovascular therapy.
Identifiants
pubmed: 37533024
doi: 10.1186/s12974-023-02863-1
pii: 10.1186/s12974-023-02863-1
pmc: PMC10394867
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
182Subventions
Organisme : Forschungsrat des Kantonsspitals Aarau
ID : FR 1410.000.122
Informations de copyright
© 2023. The Author(s).
Références
J Biomed Mater Res B Appl Biomater. 2010 Aug;94(2):486-492
pubmed: 20574973
Neurosurgery. 2006 Mar;58(3):534-41; discussion 534-41
pubmed: 16528195
Brain Sci. 2020 Feb 13;10(2):
pubmed: 32069946
J Neurosurg. 2007 Jul;107(1):94-108
pubmed: 17639879
J Neurointerv Surg. 2022 Dec;14(12):1258-1263
pubmed: 35110397
Stroke. 2017 Apr;48(4):1052-1060
pubmed: 28292871
Radiology. 2010 Nov;257(2):418-26
pubmed: 20829543
Stroke. 2021 Mar;52(3):1043-1052
pubmed: 33504186
Neurosurg Rev. 2019 Mar;42(1):49-58
pubmed: 28819834
Cytokine. 2018 Feb;102:123-130
pubmed: 28969944
J Cereb Blood Flow Metab. 2020 May;40(5):922-938
pubmed: 32126875
J Vis Exp. 2014 Oct 12;(92):e51071
pubmed: 25350840
Stroke. 2014 Jan;45(1):248-54
pubmed: 24222045
J Neurointerv Surg. 2019 Oct;11(10):1050-1054
pubmed: 30852526
J Neurointerv Surg. 2010 Jun;2(2):120-30
pubmed: 21990591
J Cereb Blood Flow Metab. 2022 Sep;42(9):1568-1578
pubmed: 34796752
Neurol Res. 2013 Jan;35(1):37-43
pubmed: 23317797
J Neurointerv Surg. 2017 Jul;9(7):707-712
pubmed: 27387709
J Neurointerv Surg. 2015 Dec;7(12):926-30
pubmed: 25332413
J Neurosurg. 2019 Dec 27;:1-14
pubmed: 31881533
Int J Mol Med. 2008 Nov;22(5):595-603
pubmed: 18949379
Radiology. 1998 Jan;206(1):237-43
pubmed: 9423678
Stroke. 2004 Oct;35(10):2287-93
pubmed: 15322297
Stroke. 2007 Jan;38(1):170-6
pubmed: 17122421
J Neuroinflammation. 2012 Sep 21;9:222
pubmed: 22999528
Stroke. 2013 Dec;44(12):3613-22
pubmed: 24130141
Acta Neuropathol. 2012 Jun;123(6):773-86
pubmed: 22249619
AJNR Am J Neuroradiol. 2016 Jun;37(6):1114-21
pubmed: 26721773
AJNR Am J Neuroradiol. 2015 Jul;36(7):1216-22
pubmed: 25430855
J Neurointerv Surg. 2018 Mar;10(3):301-305
pubmed: 28450456
J Neurointerv Surg. 2017 Mar;9(3):307-310
pubmed: 26975840
PLoS Biol. 2020 Jul 14;18(7):e3000410
pubmed: 32663219